Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Adds Importation Amendment To Homeland Security Appropriations Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

The amendment, proposed by Sens. David Vitter (R-La.) and Bill Nelson (D-Fla.), would allow importation of prescription drugs for personal use from Canada.

You may also be interested in...



Drug Importation Provision Included In Homeland Security Conference Report

Conferees on the Appropriations bill agreed to a limited form of personal importation from Canada.

Drug Importation Provision Included In Homeland Security Conference Report

Conferees on the Appropriations bill agreed to a limited form of personal importation from Canada.

Senate Action On Drug Importation Is Inevitable, Health Committee's Enzi Says

The Senate has the votes needed to pass a drug importation bill, Committee Chairman Enzi asserts. Enzi opposes provisions that would require manufacturers to sell an "unlimited" amount of drugs to exporting countries, but wants a bill that would promote "equity in global pricing."

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel